This poses challenges in clinical and laboratory diagnosis of COVID, and have a bearing on clinical management and patient outcomes.
SCOPE
The scope of this document is to provide clear guidelines on prevention and treatment of co-infections of COVID with diseases like Dengue, Malaria, Seasonal Influenza (H1N1), Leptospirosis, Chikungunya etc.
CLINICAL FEATURES
As per the World Health Organization (WHO) case definition, a COVID case may present with:
• Acute onset of fever AND cough; OR
• Acute onset of ANY THREE OR MORE of the following signs or symptoms: fever, cough, general weakness/ fatigue, headache, myalgia, sore throat, coryza, dyspnoea, anorexia/ nausea/ vomiting, diarrhoea, altered mental status.
This case definition, although sensitive, is not very specific. Seasonal epidemic-prone diseases, as cited in the foregoing paragraphs may all present as febrile illness, with symptoms that mimic COVID-19. If there is a coinfection, then apart from the febrile illness there may be constellation of signs and symptoms that may lead to difficulty in diagnosis. A comparative analysis of disease onset, symptoms, signs, warning signs, complications and diagnosis is given at Annexure.
APPROACH TO DIAGNOSIS OF SUSPECTED CO-INFECTION
Denne historien er fra December 2020-utgaven av Future Medicine India.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent ? Logg på
Denne historien er fra December 2020-utgaven av Future Medicine India.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent? Logg på
VACCINES IN YOUR POCKET
DR. SAUMYA SWAMINATHAN Cheif Scientist, World Health Organisation
DIABETES, AT CLOSE TO 91 MILLION CASES, ACCOUNTS FOR 25% OF ALL NCDS IN INDIA
The disease incidence, which increases very rapidly in individuals above 35 years of age, accounts for 12.8 million DALYs, 6.7 million YLDs
EXPERTS PREDICT THIRD WAVE IN INDIA WITH MORE THAN A LAKH DAILY CASES IN FEBRUARY
The active cases have come down as compared July leveld, the threat of new variants is looming large.
END INEQUALITIES TO MEET THE TARGET OF ENDING AIDS
Forty years after the first AIDS case was reported, and 35 years since the first case in India, HIV still threatens us. Today, the world is off track from delivering on the shared commitment to end AIDS by 2030.
UK approves sotrovimab as new covid treatment for high risk adults
The Medicines and Healthcare Products Regulatory Agency (MHRA), the drug regulator of the UK, has approved sotrovimab, branded as Xevudy, a new biological drug to fight Covid-19. The drug was found effective to reduce the likelihood of hospital admission and death by about 79 percent in high-risk adults.
Critical Use Of Tractography In Removal Of Brain Tumours
Among Indian surgeons, it is rare to find the skilful art of using Diffusion Tensor Imaging-Fiber Tractography (DTI-FT), a novel MRI technique, to locate the facial nerve on the surface of the brain tumour before surgery
DIGITAL THERAPEUTICS: CHANGING PARADIGMS IN DIABETES CARE
With the emergence of DTx programs, doctors and healthcare staffcan extend their care and monitor a patient remotely for faster recovery
ROLE OF NUTRACEUTICALS IN MODERN HEALTHCARE
With the pandemic teaching us the importance of overall nutrition, people are getting more flexible toward nutraceuticals
Liposomal Nanotechnology and its role in vaccine delivery systems
In the recent past, there have been many projects to develop sub-unit vaccines that are more effective and defined
CIDRAP RELEASES INFLUENZA VACCINES R&D ROADMAP TO IMPROVE FLU VACCINES
The Center for Infectious Disease Research and Policy (CIDRAP) at the University of Minnesota, has released an Influenza Vaccines Research and Development Roadmap (IVR) to accelerate the development of improved seasonal influenza vaccines and the generation of broadly protective or universal influenza vaccines that could mitigate the impact of future influenza pandemics.